This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Denali scores record-breaking $217mm Series A financing
15 May 2015
In the largest biopharma Series A round to date, Fidelity Biosciences, Arch Venture Partners, Flagship Ventures, the Alaska Permanent Fund (represented by Crestline Investors), sovereign wealth funds, public mutual funds, and private family offices committed $217mm in Series A financing for Denali Therapeutics Inc. (neurodegenerative diseases). Fidelity, Arch, and Flagship have representation on the start-up's board.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?